Omepac Adverse Reactions

Capsule: OMEPAC 20 is well tolerated. Nausea, headache, diarrhea, constipation and flatulence have been reported occasionally. Rarely skin rash has occurred in a few patients. These effects are mild and transient and bear no consistent relationship with treatment.
Injection: Most frequent adverse effects experienced with Omeprazole have been headache, diarrhea and skin rashes. They have sometimes been severe enough to discontinue the treatment. Other adverse effects include pruritus, dizziness, fatigue, constipation, nausea and vomiting, flatulence, abdominal pain, arthralgia and myalgia, urticaria, and dry mouth. Isolated cases of photosensitivity, bullous eruption, erythema multiforme, angioedema, and anaphylaxis have been reported. Effects on the CNS include occasional insomnia, somnolence, and vertigo; reversible confusional states, agitation, depression, and hallucination have occurred in severely ill patients. Raised liver enzymes, and isolated cases of hepatitis, jaundice and hepatic encephalopathy, have been reported. Other adverse effects reported rarely or in isolated cases include paraesthesia, blurred vision, alopecia, stomatitis, taste disturbances, peripheral edema, blood disorders including agranulocytosis, leucopenia, and thrombocytopenia, and interstitial nephritis.
Proton pump inhibitors may increase the risk of gastrointestinal infections because of their acid suppressive effects.